Posted Raghav Somani
A decade ago, when the Wharton Business Plan Competition (BPC) began, the Internet dominated discussions about entrepreneurship. That, of course, was before the bubble burst and many dot-coms were revealed to be, in the words of New Yorker writer John Cassidy, little more than dot- cons.
These days, the Internet remains a critical enabler of commerce, but no one pretends that staking out a little real estate on the Web will ensure business success. Instead, student entrepreneurs who compete in the Wharton BPC have recently turned their attention to another promising arena: health care–specifically biotechnology, that combination of medicine, basic science and engineering that has unraveled the human genome and, if it lives up to its promise, could deliver a raft of new treatments for a variety of diseases.
Five of the eight finalists at this year’s Venture Finals–the culminating event in the year-long business-plan competition–offered up ideas for businesses that could help people live longer or less painful lives. They ranged from one as simple as creating better padding for the junctures between prostheses and amputees’ residual limbs to one as complex as using nanoparticles–infinitesimally small specks of matter–to better diagnose and treat cancer.
Other health-related ideas included a gel that would replace damaged knee cartilage, a drug to prevent a common form of blindness, processes for embedding pipes with bacteria killers and a medical device to stop tumor growth. Rounding out this year’s finalists were software that would aid in patent applications and a process for tinting windows with a pulse of electricity.
The Wharton BPC, open to any team that includes a University of Pennsylvania student, lasts much of the academic year. In the fall, hundreds of teams present briefs of business ideas. By the late spring, that group is winnowed down to 25 semi-finalists, who prepare full-fledged business plans. The eight finalists are selected based on these plans.
At the Venture Finals on April 30, a panel of four judges evaluated the finalists, listening to a 10-minute presentation from each, before subjecting each to 10 minutes of interrogation. The judges, all investment professionals and Wharton alumni, came from Cardinal Partners, Weston Presidio, Schering-Plough (nyse: SGP – news - people ) and Felicis Ventures.
Read the rest of this entry »
Recent Member Comments